about
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasetsMicroRNAs in the DNA Damage/Repair Network and CancerMechanisms of change in gene copy numberMicroRNA-210: a unique and pleiotropic hypoxamirMiR-210--micromanager of the hypoxia pathwayHypoxamiRs and cancer: from biology to targeted therapyImaging tumor hypoxia to advance radiation oncologyMicroRNA regulation of DNA repair gene expression in hypoxic stressDown-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroidsAtypical Role for PhoU in Mutagenic Break Repair under Stress in Escherichia coliGenetic Instability Caused by Loss of MutS Homologue 3 in Human Colorectal CancerDefining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsAntiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.A microhomology-mediated break-induced replication model for the origin of human copy number variation.Aberrant epigenetic silencing is triggered by a transient reduction in gene expressionEffects of acute versus chronic hypoxia on DNA damage responses and genomic instability.Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer.Redox regulation of DNA repair: implications for human health and cancer therapeutic development.Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms.Medicine. Combating evolution to fight disease.The sigma(E) stress response is required for stress-induced mutation and amplification in Escherichia coli.Activation of Hif1α by the prolylhydroxylase inhibitor dimethyoxalyglycine decreases radiosensitivity.Application of molecular diagnostics for the detection of Lynch syndrome.Separate DNA Pol II- and Pol IV-dependent pathways of stress-induced mutation during double-strand-break repair in Escherichia coli are controlled by RpoS.The origins of cancer robustness and evolvability.p53 Ser15 phosphorylation disrupts the p53-RPA70 complex and induces RPA70-mediated DNA repair in hypoxia.Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences.NFAT5 is activated by hypoxia: role in ischemia and reperfusion in the rat kidney.Environmentally responsive genome-wide accumulation of de novo Arabidopsis thaliana mutations and epimutationsIn vitro CO2-induced ROS production impairs cell cycle in SH-SY5Y neuroblastoma cells.Transcriptome analysis of the spalax hypoxia survival response includes suppression of apoptosis and tight control of angiogenesis.EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenationTumor hypoxia and genetic alterations in sporadic cancers.Hypoxia and radiation therapy: past history, ongoing research, and future promise.Engineered proteins detect spontaneous DNA breakage in human and bacterial cells.Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistanceAPE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.Requirement of evading apoptosis for HIF-1α-induced malignant progression in mouse cells.miR-210: fine-tuning the hypoxic response.
P2860
Q21183974-10AFD8B4-1974-4F2A-B171-AEEB8C113D84Q21284509-0EC47CD8-E99A-4106-A2E6-1594CF089F1DQ22122003-FFB9B96F-4D3D-4786-AA58-C0D4C23EB0C8Q24601095-8CB9DDB4-6038-409E-A0C5-C6F0B31F1177Q24628401-4127E37E-5896-4CCE-8A58-2E8E73D77C7AQ26863298-E0B8BC3A-24DE-4A40-8910-E1FDCCD20DF8Q27007862-B7CCDBE4-D57C-4403-B107-F9D2C639C9CCQ28306694-FE190C6A-2343-43B0-AE01-E823EAC01565Q28478209-99A15BDD-DDBD-438B-9A91-46A95FFDAF4EQ28547150-1C4DBF06-75A8-4707-80C6-822695AC482FQ29395710-FB865A05-1EB9-4A0E-AD84-C679AEA0021FQ29615944-6B30120D-2A6A-4931-AFF1-B28C3C89D065Q30399006-4034CF3B-F4A3-4047-8658-7D5C47FF2986Q33404060-99EEE27E-0889-4351-92AE-F76802A0FC1FQ33417274-5D820DB9-219B-4BD9-B14E-8940995A8CFBQ33526747-EE86164B-68A5-4AB5-806E-B7E7D06803A8Q33644570-98FD6549-8FF0-4EDB-9A0C-D8956F06A91CQ33830130-FD8EEC67-3FB3-4FFC-8F8C-67720753B945Q33889555-A14C3651-D038-4643-9EF3-2CF5789A45C8Q33980301-6A04E849-21C5-4F2E-A9F9-694F37C2FB97Q34017416-5BF86293-0900-4F3D-84B2-30B90B5EBC04Q34053479-5662596F-36B7-4942-B7BA-7B42FC4561B3Q34088809-54C4867F-0FEF-4471-A4A6-F63567736F8DQ34119281-EAC98F8F-18C2-45EA-9A70-2F13BEDC17F0Q34143477-E9FAEA1F-913B-454C-9ADC-76C71E0993B4Q34144537-F32225DE-5304-45A4-847E-D468B6978F68Q34210210-A5EE2AC4-3DEA-4D23-B47E-2ACF19950226Q34328986-30C4D2C0-9A9D-462C-B264-B27EBDC66086Q34439376-B9750A0C-0403-45FF-B5D5-C7636BAF8B8EQ34466270-D96E3804-BCF3-4F58-B78C-F20FF1208D28Q34475725-650ABC07-928D-4FF7-9EE7-A2EEC16EEF53Q34584872-3A554BC5-5D1D-40FD-B288-9E46C2A82CB0Q34613520-C5BA42CB-6CBE-4D17-83D2-424557675351Q34813119-3BA3B9D4-3BA6-4EBD-921A-6CAB4F981BB5Q34986265-AB57C3A9-CA70-4691-834A-DEDCA4B4D1CFQ35028595-FF0BCE4C-8F43-4B70-8383-3883573C731BQ35219886-55827B4B-EEB7-41BA-A56E-9369966223FCQ35870045-6CA02C35-BBAF-4F5D-9950-C126256E8F95Q35878522-C93DAFB5-2AD1-49A6-B109-61867DC1F61EQ35891149-2280B694-5E47-424A-AFB9-90B410A6A0A4
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Regulation of DNA repair in hypoxic cancer cells.
@en
type
label
Regulation of DNA repair in hypoxic cancer cells.
@en
prefLabel
Regulation of DNA repair in hypoxic cancer cells.
@en
P2093
P2860
P1476
Regulation of DNA repair in hypoxic cancer cells.
@en
P2093
Meredith E Crosby
Peter M Glazer
Ranjit S Bindra
P2860
P2888
P304
P356
10.1007/S10555-007-9061-3
P577
2007-06-01T00:00:00Z